2023
DOI: 10.1016/j.joca.2023.01.573
|View full text |Cite
|
Sign up to set email alerts
|

Sustained intra-cartilage delivery of interleukin-1 receptor antagonist using cationic peptide and protein-based carriers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 41 publications
0
12
0
Order By: Relevance
“…46 These principles of optimal net charge design based on the negative fixed charge density of tissues were confirmed and successfully applied to the development of cartilage targeting carriers in our previous work. [47][48][49][50][51] Remarkably, mExo-AP and mExo-BP demonstrated enhanced uptake in Caco-2 cells compared to other formulations, with improvements of 1.5-fold and 2.5-fold compared to native mExo, respectively (Fig. 4B).…”
Section: Biomaterials Science Papermentioning
confidence: 88%
See 1 more Smart Citation
“…46 These principles of optimal net charge design based on the negative fixed charge density of tissues were confirmed and successfully applied to the development of cartilage targeting carriers in our previous work. [47][48][49][50][51] Remarkably, mExo-AP and mExo-BP demonstrated enhanced uptake in Caco-2 cells compared to other formulations, with improvements of 1.5-fold and 2.5-fold compared to native mExo, respectively (Fig. 4B).…”
Section: Biomaterials Science Papermentioning
confidence: 88%
“…46 These principles of optimal net charge design based on the negative fixed charge density of tissues were confirmed and successfully applied to the development of cartilage targeting carriers in our previous work. 47–51…”
Section: Discussionmentioning
confidence: 99%
“…Both mAv and CPC at 2× higher working concentrations were safe to use as no changes in cell viability, metabolism, or effects on relative GAG loss and nitrite release from cartilage explants were observed compared to saline control. While mAv has been successfully used for delivery of small molecule drugs to cartilage in low doses, ,,,, CT imaging requires many folds higher IOX doses compared to drugs. This may require mAv’s use at concentrations higher than 100 μM that have been shown to be safe .…”
Section: Discussionmentioning
confidence: 99%
“…This can be helpful especially in monitoring patients with traumatic joint injuries who are at a high risk of developing OA in future . Our laboratory has designed cartilage targeting optimally charged cationic carriers that possess sufficient electrical driving force to rapidly carry the conjugated cargo through the full thickness of cartilage tissue in high concentrations following their intra-articular administration in the synovial joint. Here we use an arginine rich cationic peptide carrier with net charge of +8 (CPC, (RRAAAA) 3 RR) and a cationic multi-arm PEGylated Avidin (mAv) nanoconstruct ,, for intra-cartilage delivery of IOX as both carriers can rapidly penetrate through the full thickness of healthy and OA cartilage resulting in about 100× higher uptake than uncharged carriers. These carriers are designed to possess optimal cationic charge based on cartilage tissue’s negative fixed charge density (FCD) that enables high Donnan partitioning ( K CPC = 7.6; K mAv = 6) at the synovial fluid–cartilage interface resulting in steep intra-tissue concentration gradients and thus facilitating rapid transport and high uptake. Too high of a cationic charge on the carrier can result in strong binding with cartilage GAGs in the superficial zone, preventing their penetration (Figure B).…”
mentioning
confidence: 99%
“…Cationic nanocarriers that form weak electrostatic interactions with the anionic cartilage ECM can be an effective approach to overcome the electrostatic barrier 12–18 . For an effective therapeutic outcome, the nanocarriers first need to adhere to the cartilage tissue, and then penetrate and be retained throughout the full‐thickness cartilage 19 .…”
Section: Introductionmentioning
confidence: 99%